内膜增生、大隐静脉移植物病变与临床结局:CTSN VEST随机试验的启示
VEST是一项患者内随机、多中心试验,纳入224例多支冠状动脉病变行冠状动脉旁路移植术的患者,203例在术后1年接受评估。本二次分析发现,术后1年大隐静脉移植物病变越重、内膜增生面积越大,3年主要心脑血管不良事件发生率越高;术后1年移植物闭塞的危险因素包括内镜下静脉获取、女性、以及瞬时血流测量中的搏动指数和流量。
要点
- 管腔均匀性越差、狭窄越重、移植物灌注越差,与内膜增生值更高及临床事件发生率增加相关。
- 术后1年大隐静脉移植物闭塞的危险因素包括内镜下静脉获取、女性、瞬时血流测量的搏动指数和流量。
- 更严重的大隐静脉移植物病变和更大面积的内膜增生与更高的3年主要心脑血管不良事件发生率相关。
核心结论
- 在VEST试验的二次分析中,观察到术后1年内膜增生面积与大隐静脉移植物病变的临床指标之间存在关联。
- 更严重的大隐静脉移植物病变和更大面积的内膜增生与更高的3年主要心脑血管不良事件发生率相关。
- 持续随访至5年将进一步阐明大隐静脉移植物病变对冠状动脉旁路移植术长期临床结局的影响。
研究设计与样本
- VEST为患者内随机、多中心试验,纳入224例接受冠状动脉旁路移植术的多支冠状动脉病变患者,其中203例在术后1年接受评估。
- 采用血管内超声和血管造影测量内膜增生、管腔均匀性、移植物狭窄和移植物灌注。
- 主要心脑血管不良事件(包括死亡、心肌梗死、卒中和血运重建)在中位3年随访期内记录。
主要发现
- 管腔均匀性越差、狭窄越重、移植物灌注越差,与内膜增生值更高及临床事件发生率增加相关。
- 术后1年大隐静脉移植物闭塞的危险因素包括内镜下静脉获取、女性、以及瞬时血流测量中的搏动指数和流量。
- 更严重的大隐静脉移植物病变和更大面积的内膜增生与更高的3年主要心脑血管不良事件发生率相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Diffuse intimal hyperplasia and graft irregularity adversely affect the long-term patency of saphenous vein grafts (SVGs) and clinical outcomes of patients undergoing coronary artery bypass grafting (CABG). The VEST trial evaluated the efficacy of external graft support in limiting the development of intimal hyperplasia (IH) at 1 year postsurgery. In the present secondary analysis, we explored the associations between graft disease and IH and clinical events. We also examined risk factors for early graft occlusion. METHODS: VEST is a within-patient randomized, multicenter trial that enrolled 224 patients with multivessel coronary disease undergoing CABG surgery, of whom 203 were evaluated by 1 year postsurgery. Intimal hyperplasia, lumen uniformity, graft stenosis, and graft perfusion were measured by intravascular ultrasound and angiography. Major cardiac and cerebrovascular events (MACCE; including death, myocardial infarction, stroke, and revascularization) were recorded over a median follow-up of 3 years. RESULTS: Worse lumen uniformity, greater stenosis, and worse graft perfusion were associated with higher IH values and an increased incidence of clinical events. Consistent with previous findings, we identified endoscopic vein harvesting, female sex, and transit time flow measurement of pulsatility index and flow as risk factors for SVG occlusion during the first year postsurgery. CONCLUSIONS: In this secondary analysis of the VEST trial, we observed an association between intimal hyperplasia area and clinical measures of SVG disease at 1 year postsurgery. More severe SVG disease and larger areas of IH were associated with a higher incidence of 3-year MACCE. Ongoing follow-up to 5 years will further elucidate the impact of SVG disease on long-term clinical outcomes of CABG.
引用
- Goldstein DJ, Chang HL, Mack MJ, et al. Intimal hyperplasia, saphenous vein graft disease, and clinical outcomes: Insights from the CTSN VEST randomized trial. J Thorac Cardiovasc Surg. 2022. PMID: 36494209. doi:10.1016/j.jtcvs.2022.10.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。